title: [Current and future indications for bendamustine: chronic lymphocytic leukemia, indolent lymphoma, mantle cell lymphoma and diffuse large B-cell lymphomas].
authors: Klinik I für Innere Medizin, Universitätsklinik Köln, Deutschland.
authors: Michael
authors: M
authors: Hallek
authors: Wolfgang
authors: W
authors: Knauf
authors: Martin
authors: M
authors: Dreyling
authors: Lorenz
authors: L
authors: Trümper
mesh_terms: D000818:Animals; D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage; D000069461:Bendamustine Hydrochloride; D004305:Dose-Response Relationship, Drug; D005544:Forecasting; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000188:drug therapy*; D008223:Lymphoma / Q000188:drug therapy*; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage*
chemical_list: D018906:Antineoplastic Agents, Alkylating; D009588:Nitrogen Mustard Compounds; D000069461:Bendamustine Hydrochloride